269 related articles for article (PubMed ID: 19465145)
1. Cytogenetic assessment of methylphenidate treatment in pediatric patients treated for attention deficit hyperactivity disorder.
Tucker JD; Suter W; Petibone DM; Thomas RA; Bailey NL; Zhou Y; Zhao Y; Muniz R; Kumar V
Mutat Res; 2009; 677(1-2):53-8. PubMed ID: 19465145
[TBL] [Abstract][Full Text] [Related]
2. Absence of cytogenetic effects in children and adults with attention-deficit/hyperactivity disorder treated with methylphenidate.
Ponsa I; Ramos-Quiroga JA; Ribasés M; Bosch R; Bielsa A; Ordeig MT; Morell M; Miró R; de Cid R; Estivill X; Casas M; Bayés M; Cormand B; Hervás A
Mutat Res; 2009 Jun; 666(1-2):44-9. PubMed ID: 19457516
[TBL] [Abstract][Full Text] [Related]
3. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
Walitza S; Kämpf K; Artamonov N; Romanos M; Gnana Oli R; Wirth S; Warnke A; Gerlach M; Stopper H
Toxicol Lett; 2009 Jan; 184(1):38-43. PubMed ID: 19015014
[TBL] [Abstract][Full Text] [Related]
4. Prospective follow-up studies found no chromosomal mutagenicity of methylphenidate therapy in ADHD affected children.
Walitza S; Kämpf K; Oli RG; Warnke A; Gerlach M; Stopper H
Toxicol Lett; 2010 Mar; 193(1):4-8. PubMed ID: 20026394
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic effects in children treated with methylphenidate.
El-Zein RA; Abdel-Rahman SZ; Hay MJ; Lopez MS; Bondy ML; Morris DL; Legator MS
Cancer Lett; 2005 Dec; 230(2):284-91. PubMed ID: 16297714
[TBL] [Abstract][Full Text] [Related]
6. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.
Marcus SC; Wan GJ; Kemner JE; Olfson M
Arch Pediatr Adolesc Med; 2005 Jun; 159(6):572-8. PubMed ID: 15939858
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of oral osmotic-methylphenidate in treatment of attention deficit hyperactivity disorder in children].
Pan XX; Ma HW; Wan B; Dai XM
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug; 10(4):471-4. PubMed ID: 18706164
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric detection of Pig-A mutant red blood cells using an erythroid-specific antibody: application of the method for evaluating the in vivo genotoxicity of methylphenidate in adolescent rats.
Dobrovolsky VN; Boctor SY; Twaddle NC; Doerge DR; Bishop ME; Manjanatha MG; Kimoto T; Miura D; Heflich RH; Ferguson SA
Environ Mol Mutagen; 2010 Mar; 51(2):138-45. PubMed ID: 19658152
[TBL] [Abstract][Full Text] [Related]
9. Comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al.
Preston RJ; Kollins SH; Swanson JM; Greenhill LL; Wigal T; Elliott GR; Vitiello B
Cancer Lett; 2005 Dec; 230(2):292-4. PubMed ID: 16019134
[No Abstract] [Full Text] [Related]
10. Methylphenidate is not clastogenic in cultured human lymphocytes and in the mouse bone-marrow micronucleus test.
Suter W; Martus HJ; Elhajouji A
Mutat Res; 2006 Sep; 607(2):153-9. PubMed ID: 16829163
[TBL] [Abstract][Full Text] [Related]
11. Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder?
Walitza S; Werner B; Romanos M; Warnke A; Gerlach M; Stopper H
Environ Health Perspect; 2007 Jun; 115(6):936-40. PubMed ID: 17589603
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
[TBL] [Abstract][Full Text] [Related]
13. Response to comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al.
El-Zein RA; Hay MJ; Lopez MS; Bondy ML; Morris DL; Legator MS; Abdel-Rahman SZ
Cancer Lett; 2006 Jan; 231(1):146-8. PubMed ID: 16290920
[No Abstract] [Full Text] [Related]
14. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
[TBL] [Abstract][Full Text] [Related]
15. [The effects of methylphenidate on various components of visual attention in children with attention-deficit hyperactivity disorder].
Durukan I; Türkbay T; Cöngöloğlu A
Turk Psikiyatri Derg; 2008; 19(4):358-64. PubMed ID: 19110977
[TBL] [Abstract][Full Text] [Related]
16. Child characteristics and receipt of stimulant medications: a population-based study.
Miller AR; Kohen D; Johnston C
Ambul Pediatr; 2008; 8(3):175-81. PubMed ID: 18501864
[TBL] [Abstract][Full Text] [Related]
17. Age-related increase of baseline frequencies of sister chromatid exchanges, chromosome aberrations, and micronuclei in human lymphocytes.
Bolognesi C; Abbondandolo A; Barale R; Casalone R; Dalprà L; De Ferrari M; Degrassi F; Forni A; Lamberti L; Lando C; Migliore L; Padovani P; Pasquini R; Puntoni R; Sbrana I; Stella M; Bonassi S
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):249-56. PubMed ID: 9107430
[TBL] [Abstract][Full Text] [Related]
18. [Benefit of the extended-release methylphenidate formulations: a comparative study in childhood].
Favreau A; Deseille-Turlotte G; Brault F; Giraudeau B; Krier C; Barthez MA; Castelnau P
Arch Pediatr; 2006 May; 13(5):442-8. PubMed ID: 16597499
[TBL] [Abstract][Full Text] [Related]
19. Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial.
Golubchik P; Sever J; Zalsman G; Weizman A
Int Clin Psychopharmacol; 2008 Jul; 23(4):228-31. PubMed ID: 18446088
[TBL] [Abstract][Full Text] [Related]
20. Association between homozygosity of a G allele of the alpha-2a-adrenergic receptor gene and methylphenidate response in Korean children and adolescents with attention-deficit/hyperactivity disorder.
Cheon KA; Cho DY; Koo MS; Song DH; Namkoong K
Biol Psychiatry; 2009 Apr; 65(7):564-70. PubMed ID: 19150055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
